全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Henry S. Eden , Joshua M. Farber
来源:[J].Journal of Controlled Release(IF 7.633), 2012, Vol.157 (2), pp.216-223Elsevier
摘要:Abstract(#br)Tumors expressing the chemokine receptor CXCR4 have been reported to be more aggressive and to produce more metastatic seeding in specific organs, such as the bone marrow. However, evaluation of tumors for CXCR4 expression requires testing of ex vivo biopsy samples, ...
作者:Xiao-Xiang Zhang , Henry S. Eden , Xiaoyuan Chen
来源:[J].Journal of Controlled Release(IF 7.633), 2012, Vol.159 (1), pp.2-13Elsevier
摘要:Abstract(#br)Peptides are attracting increasing attention as therapeutic agents, as the technologies for peptide development and manufacture continue to mature. Concurrently, with booming research in nanotechnology for biomedical applications, peptides have been studied as an imp...
作者:Henry S. Eden , Yulong He ...
来源:[J].Amino Acids(IF 3.914), 2012, Vol.42 (6), pp.2343-2351Springer
摘要:Abstract(#br)Lymphangiogenesis in tumor-draining lymph nodes (LNs) starts before the onset of metastasis and is associated with metastasis to distant LNs and organs. In this study, we aimed to visualize tumor-induced lymphangiogenesis with a tumor lymphatics-specific peptide...
作者:Henry S. Eden , Gang Niu
来源:[J].European Journal of Nuclear Medicine and Molecular Imaging(IF 5.114), 2011, Vol.38 (10)Springer
摘要:Abstract(#br) Purpose(#br)Tumor endothelial marker 8 (TEM8) has been reported to be upregulated in both tumor cells and tumor-associated endothelial cells in several cancer types. TEM8 antagonists and TEM8-targeted delivery of toxins have been developed as effective cancer t...
作者:Henry S. Eden , Baozhong Shen
来源:[J].Contrast Media & Molecular Imaging(IF 2.872), 2012, Vol.7 (4), pp.363-372Wiley
摘要:The purpose of this study was to synthesize, characterize and tailor the surface properties of magnetic nanoparticles with biocompatible copolymer coatings and to evaluate the efficiency of the resulting nanoconjugates as magnetic resonance imaging (MRI) contrast agents for ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×